Gene: CYB5R4
Official Full Name: cytochrome b5 reductase 4provided by HGNC
Gene Summary: NCB5OR is a flavohemoprotein that contains functional domains found in both cytochrome b5 (CYB5A; MIM 613218) and CYB5 reductase (CYB5R3; MIM 613213) (Zhu et al., 1999 [PubMed 10611283]).[supplied by OMIM, Jan 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22911 | CYB5R4 Knockout cell line (HeLa) | Human | CYB5R4 | 1:3~1:6 | Negative | Online Inquiry |
KO22912 | CYB5R4 Knockout cell line (HCT 116) | Human | CYB5R4 | 1:2~1:4 | Negative | Online Inquiry |
KO22913 | CYB5R4 Knockout cell line (HEK293) | Human | CYB5R4 | 1:3~1:6 | Negative | Online Inquiry |
KO22914 | CYB5R4 Knockout cell line (A549) | Human | CYB5R4 | 1:3~1:4 | Negative | Online Inquiry |
CYB5R4 Gene Knockout Cell Lines are advanced, genetically modified cellular systems designed to facilitate the study of cytochrome b5 reductase 4 (CYB5R4) gene function. These cell lines are engineered to lack the CYB5R4 gene, allowing researchers to observe the physiological and biochemical changes that occur in its absence. CYB5R4 plays a critical role in electron transfer processes in various cellular pathways, which makes these knockout models invaluable for elucidating mechanisms underlying metabolic diseases and drug metabolism.
The key function of CYB5R4 involves its participation in the reduction of methemoglobin to hemoglobin, impacting oxygen transport within tissues. Additionally, it is implicated in the metabolism of fatty acids and the detoxification of xenobiotics. By utilizing our CYB5R4 knockout cell lines, researchers can effectively study these essential pathways and the consequences of CYB5R4 loss, leading to a better understanding of associated disorders, such as hemoglobinopathies and conditions linked to oxidative stress.
Scientifically, these cell lines serve as vital tools in both research and clinical settings. They offer the capability to explore therapeutic targets and the pharmacogenetic implications of CYB5R4 on drug efficacy and toxicity. The knockout models can also support high-throughput screening processes for novel compounds aimed at restoring normal cellular function or mitigating disease.
Compared to conventional alternatives, our CYB5R4 Gene Knockout Cell Lines are characterized by their precise CRISPR-Cas9 editing technology, ensuring a clean and reproducible knockout without off-target effects. This precision enhances the reliability of experimental outcomes and minimizes potential confounding variables. Furthermore, these cell lines are rigorously tested for stability and functional phenotype, providing researchers with a robust platform for their studies.
The value of CYB5R4 Gene Knockout Cell Lines to researchers and clinicians is profound; they empower innovative research into metabolic pathways, potentially translating into improved therapeutic strategies. Our company specializes in delivering high-quality biological products backed by extensive expertise in genomic engineering and cellular biology, ensuring that customers receive not just a product, but a reliable partner in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.